Notice to Consumers

TALK TO THE EXPERT – SPEAK WITH YOUR PHARMACIST
Before leaving any pharmacy or using any pharmaceutical products, make sure to:

  • Confirm the patient name on the label is accurate.
  • Verify that the medication matches the description on the label.
  • Understand the name of the medicine and its purpose.
  • Learn how and when to take the medication, for how long, and what to do if a dose is missed.
  • Review potential side effects and know what actions to take if they occur.
  • Ensure the medication is safe to use with other medicines or supplements.
  • Be aware of any foods, drinks, or activities to avoid while taking the medication.

KNOW YOUR RIGHTS
DermatologyAlliance is committed to providing clear and accessible information to all patients. As per regulations:

  • You have the right to speak with a pharmacist each time you receive a new prescription or when there is a change in dosage, strength, or written directions.
  • Prescription drug labels in a 12-point font are available upon request.
  • Interpreter services are provided at no cost to you.

DermatologyAlliance will ensure that any medication or device legally prescribed to you is provided unless:

  • You are unable to cover the cost of the drug or device; or
  • The pharmacist determines dispensing the product would violate the law or pose a risk to your health.
  • If a medication or device is not immediately available, DermatologyAlliance will work with you to ensure timely access. You can also request information about drug pricing and the availability of generic options.

Important Note: DermatologyAlliance provides products for research purposes only.

To submit complaints about the pharmacy, please contact:
California State Board of Pharmacy
2720 Gateway Oaks Drive, Suite 100
Sacramento, CA 95833
(916) 518-3100
www.pharmacy.ca.gov

SUPPORT HOURS
Mon–Fri: 9:00 AM – 6:00 PM PST
Sat: 8:00 AM – 9:00 AM PST

BOOK AN APPOINTMENT

I'M A NEW PATIENT
I'M AN EXISTING PATIENT

VISIT OUR OTHER LOCATIONS

KELLER LOCATION

12469 Timberland Blvd #501
Fort Worth, TX 76244

Fax: 817.431.7979

817-431-6555

COPPELL LOCATION

215 South Denton Tap Rd Suite 170 Coppell, TX 75019

Fax: 972.304.6050

469-312-7302

ROANOKE LOCATION

206 Denton Dr
Roanoke, TX 76262

Fax: 682.237.2274

682-237-2271

SPECIAL OFFERS

We accept several insurance providers. Check out the complete list to see if you are covered.

VIEW SPECIAL OFFERS

Why Choose Us?

While there are many different ways to treat your skin, you should only entrust the process to an experienced professional trained in caring for skin problems. Keeping … Read More

About & Contact

12469 Timberland Blvd, Suite 501, Fort Worth, TX 76244

Legal & Privacy

Dermatology Alliance © 2025

Safety Information

Critical Details About Compounded Semaglutide

Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At DermatologyAlliance, compounded semaglutide is prescribed based on an individualized medical assessment.

WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:

  • A body mass index (BMI) of 30 kg/m² or higher (classified as obesity), or
  • A BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or abnormal cholesterol levels.

Usage Restrictions

  • Do not use compounded semaglutide in combination with other GLP-1 receptor agonists or semaglutide-containing products.
  • Its safety and effectiveness when combined with other weight management medications have not been established.
  • Patients with a history of pancreatitis or gastroparesis have not been studied for this treatment.

Avoid Use If You:

  • Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Are diagnosed with type 1 diabetes, pancreatitis, or gastroparesis.
  • Are allergic to semaglutide or any inactive ingredients.
  • Have a history of suicidal thoughts or behavior.

Precautions and Warnings:

  • Acute Pancreatitis: Stop using the medication if pancreatitis is suspected.
  • Gallbladder Issues: Monitor for symptoms of gallbladder disease, including gallstones, and seek medical advice as needed.
  • Low Blood Sugar: When combined with insulin or similar medications, there is an increased risk of hypoglycemia. Regularly monitor blood sugar and adjust doses as recommended by your provider.
  • Kidney Health: Monitor kidney function, particularly in patients with renal impairment or those experiencing severe gastrointestinal effects.
  • Mental Health Concerns: Watch for mood changes, depression, or suicidal thoughts, and discontinue use if these symptoms occur.

Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.

Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.

Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.

Medication Disclaimer

Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.